help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 51, No. 5 968-971
doi:10.1210/jcem-51-5-968
Copyright © 1980 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TUCKER, H. ST. G.
Right arrow Articles by BLACKARD, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TUCKER, H. ST. G.
Right arrow Articles by BLACKARD, W. G.

Persistent Defect in Regulation of Prolactin Secretion after Successful Pituitary Tumor Removal in Women with the Galactorrhea-Amenorrhea Syndrome*

H. ST. GEORGE TUCKER, HARVEY V. LANKFORD, DAVID F. GARDNER and WILLIAM G. BLACKARD

Division of Endocrinology, Department of Medicine, Virginia Commonwealth University, Medical College of Virginia Richmond, Virginia 23298

Address requests for reprints to: Dr. H. St. George Tucker, Medical College of Virginia, Virginia Commonwealth University, MCV Station, Richmond, Virginia 23298.

TRH, metoclopramide (MCP), chlorpromazine (CPZ), and insulin (ITT) stimulation tests of PRL secretion were carried out in age-matched controls and before and after successful removal of pituitary prolactinomas in women with the galactorrhea-amenorrhea syndrome. In preoperative patients there was a blunted or absent PRL response to TRH in 87%, to MCP in 100%, to CPZ in 100%, and to ITT in 93%. Two to 6 months after successful tumor removal, serum PRL rose 2-fold (the usual criterion for a normal response) in 73% after TRH, in 100% after MCP, but in only 13% after CPZ and in only 14% on ITT. However, the PRL increment with all four tests was significantly lower than that in normal controls. One to 8 yr after successful surgery, the PRL increments after TRH and MCP were returning to normal, but the PRL responses to CPZ and ITT remained blunted. GH, ACTH, and TSH reserves were intact in all patients. The diminished PRL response to all stimulation tests observed up to 6 months postoperatively might be explained by the persistence of a negative feedback effect from high PRL levels associated with the tumor. The more persistent impairment of the PRL response to CPZ and ITT is unexplained but suggests a hypothalamic defect.

* This work was supported by NIH Grant AMOl-RR-65.

Received April 4, 1980.




This article has been cited by other articles:


Home page
JAMAHome page
E. F. Rodman, M. E. Molitch, K. D. Post, B. J. Biller, and S. Reichlin
Long-term Follow-up of Transsphenoidal Selective Adenomectomy for Prolactinoma
JAMA, August 17, 1984; 252(7): 921 - 924.
[Abstract] [PDF]


Home page
JAMAHome page
R. F. Spark, R. Baker, D. C. Bienfang, and R. Bergland
Bromocriptine Reduces Pituitary Tumor Size and Hypersecretion: Requiem for Pituitary Surgery?
JAMA, January 15, 1982; 247(3): 311 - 316.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
H. ST. G. TUCKER, S. R. GRUBB, J. P. WIGAND, A. TAYLON, H. V. LANKFORD, W. G. BLACKARD, and D. P. BECKER
Galactorrhea-Amenorrhea Syndrome: Follow-up of Forty-Five Patients After Pituitary Tumor Removal
Ann Intern Med, March 1, 1981; 94(3): 302 - 307.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1980 by The Endocrine Society